Late toxicity in survivors from adolescent cancers

Cancer Treatment Reviews

Volumn 33, Issue 7, 2007, Pages 656-663

  Pentheroudakis, George ^a   Pavlidis, Nicholas ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Adolescent; Cancer; Late toxicity

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BLEOMYCIN; BUSULFAN; CARMUSTINE; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; METHOTREXATE; MITOMYCIN; MITOXANTRONE; NITROSOUREA DERIVATIVE; PACLITAXEL; TENIPOSIDE; TRASTUZUMAB; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALCOHOL WITHDRAWAL; ARTICLE; AVASCULAR NECROSIS; BONE MARROW HYPOPLASIA; BONE NECROSIS; BRAIN DISEASE; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CARDIOMYOPATHY; CATARACT; CHILDHOOD CANCER; CONNECTIVE TISSUE DISEASE; COUGHING; DIABETES MELLITUS; DOSIMETRY; DYSPNEA; EXERCISE; FEMALE STERILITY; FEVER; FOLLOW UP; FRACTURE; GASTROINTESTINAL DISEASE; HEART DISEASE; HEART FAILURE; HEPATITIS; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; KIDNEY DISEASE; LIFESTYLE MODIFICATION; LIVER FIBROSIS; LUNG DISEASE; LUNG FIBROSIS; LYMPH NODE DISSECTION; LYMPHOCELE; MALE STERILITY; MEDICAL RESEARCH; MOOD DISORDER; MUSCLE NECROSIS; MYELODYSPLASIA; MYOFIBROSIS; MYOPATHY; NEPHROSCLEROSIS; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; ORTHOPEDIC SURGERY; OSTEOLYSIS; OSTEOSARCOMA; PATIENT CARE; PERICARDITIS; PERIPHERAL NEUROPATHY; PHYSICAL CAPACITY; PNEUMONIA; POSTOPERATIVE PAIN; PROGNOSIS; PROSTHESIS LOOSENING; RADIATION DOSE FRACTIONATION; RESPIRATORY FAILURE; RETROGRADE EJACULATION; RISK FACTOR; SIDE EFFECT; SKIN ATROPHY; SKIN FIBROSIS; SKIN PIGMENTATION; SMOKING CESSATION; SOCIAL PSYCHOLOGY; SPINAL CORD DISEASE; TESTIS CANCER; THYROID DISEASE;

ADOLESCENT; ANTINEOPLASTIC AGENTS; DRUG TOXICITY; HUMANS; INCIDENCE; NEOPLASMS; RISK FACTORS; SURVIVAL RATE; WORLD HEALTH;

EID: 35648992930     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2007.06.002     Document Type: Article

References (74)

1. Pentheroudakis G., and Pavlidis N. Juvenile cancer: improving care for adolescents and young adults within the frame of Medical Oncology. Ann Oncol 16 (2005) 181-188
2. Moser E.C., Noordijk E.M., Carde P., et al. Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomised EORTC trials. Clin Lymphoma Myeloma 6 (2005) 122-130
3. Alerman B.M., Van der Belt-Dusebout A.W., Klokman W.J., et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 21 (2003) 3431-3439
4. Rubin P., Johnston C.J., Williams J.P., et al. A perpetual cascade of cytokines post-irradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33 (1995) 99-109
5. Hall E.J. Radiobiology for the radiologist. 4th ed. (1994), JB Lippincott, Philadelphia (PA)
6. Hill B.T. Cancer chemotherapy. The relevance of certain concepts of cell cycle kinetics. Biochem Biophys Acta 516 (1978) 389-417
7. Hochhauser D. Modulation of chemosensitivity through altered expression of cell cycle regulatory genes in cancer. Anticancer Drugs 8 (1997) 903-910
8. Offner F., Kerre T., De Smedt M., et al. Bone marrow CD34 cells generate fewer T cells in vitro with increasing age and following chemotherapy. Br J Haematol 104 (1999) 801-808
9. Rubin P. Law and order of radiation sensitivity. Absolute versus relative. In: Vaeth J.M., and Meyer J.L. (Eds). Frontiers of radiation therapy and oncology. 23rd ed. (1989), Karger, Basel 7-40
10. Mulhern R.K., and Palmer S.L. Neurocognitive late effects in pediatric cancer. Curr Probl Cancer 27 (2003) 177-197
11. Hoppe-Hirsch E., Renier D., Lellouch-Tubiana A., et al. Medulloblastoma in childhood: progressive intellectual deterioration. Childs Nerv Syst 6 (1990) 60-65
12. Reimers T.S., Ehrenfels S., Mortensen E.L., et al. Cognitive deficits in long-term survivors of childhood brain tumours: identification of predictive factors. Med Pediatr Oncol 40 (2003) 26-34
13. Haupt R., Fears T.R., Robison L.L., et al. Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. JAMA 272 (1994) 1427-1432
14. Sklar C.A., and Constine L.S. Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys 31 (1995) 1113-1121
15. Livesey E.A., and Brook C.G.D. Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Arch Dis Child 64 (1989) 593-595
16. Littley M.D., Shalet S.M., Beardwell C.G., Ahmed S.R., Applegate G., et al. Hypopuitarism following external radiotherapy for pituitary tumours in adults. Q J Med 70 (1989) 145-160
17. Spoudeas H.A., Hindmarsh P.C., Matthews D.R.M., and Brook C.G.D. Evolution of growth hormone neurosecretory disturbance after cranial irradiation for childhood brain tumours: a prospective study. J Endocrinol 150 (1996) 329-342
18. Hew F.L., O'Neal D., Kamarudin N., et al. Growth hormone deficiency and cardiovascular risk. Baillieres Clin Endocrinol Metab 12 (1998) 199-216
19. Gurney J.G., Kadan-Lottick N.S., Packer R.J., et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumours: Childhood Cancer Survivor Study. Cancer 97 (2003) 663-673
20. Talvensaari K.K., Lanning M., Tapanainen P., and Knip M. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab 81 (1996) 3051-3055
21. Oeffinger K.C., Buchanan G.R., Eshelman D.A., et al. Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 23 (2001) 424-430
22. Oeffinger K.C., and Hudson M.M. Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. CA Cancer J Clin 54 (2004) 208-236
23. Diehl V., Thomas R.K., and Re D. Part II: Hodgkin's lymphoma diagnosis and treatment. Lancet Oncol 5 (2004) 19-26
24. Hull M.C., Morris C.G., Pepine C.J., et al. Valvular dysfunction and carotid, subclavian and coronary artery disease in survivors of Hodgkin's lymphoma treated with radiation therapy. JAMA 290 (2003) 2831-2837
25. Reinders J.G., Heijmen B.J., Olofsen-van Acht M.J., et al. Ischemic heart disease after mantle field irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol 51 (1995) 35-42
26. Hancock S.L., Tucker M.A., and Hoppe R.T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270 (1993) 1949-1955
27. Mah K., Dyk J.V., Keane T., et al. Acute radiation-induced pulmonary damage: a clinical study on the response to fractionated radiation therapy. Int J Radiat Oncol Biol Phys 13 (1987) 179
28. Mertens A.C., Yasui Y., Liu Y., et al. Pulmonary complications in survivors of childhood and adolescent cancer. Cancer 95 (2002) 2431-2441
29. Hancock S.L., Cox R.S., and McDougall I.R. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 325 (1991) 599-605
30. Van Leeuwen F.E., Klokman W.J., Veer M.B., et al. Long term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18 (2000) 487-494
31. Dores G.M., Metayer C., Curtis R.E., et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 20 (2002) 3484-3494
32. Bhatia S., Yasui Y., Robison L.L., et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 21 (2003) 4386-4394
33. Koontz B.F., Kirkpatrick J.P., Clough R.W., et al. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications. J Clin Oncol 24 (2006) 605-611
34. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
35. Tefft M. Radiation-related toxicities in National Wilms' Tumour Study Study number 1. Int J Radiat Oncol Biol Phys 2 (1977) 455-463
36. Lawrence T.S., Robertson J.M., Anscher M.S., et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31 (1995) 1237-1248
37. McKay P.J., Murphy J.A., Cameron S., et al. Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant 17 (1996) 63-66
38. Glatstein E., Fajardo L.F., and Brown J.M. Radiation injury in the mouse kidney-I. Sequential light microscopic study. Int J Radiat Oncol Biol Phys 2 (1977) 933-943
39. Petersen P.M., and Hansen S.W. The course of long-term toxicity in patients treated with cisplatin-based chemotherapy for non-seminomatous germ-cell cancer. Ann Oncol 10 (1999) 1475-1483
40. Yeung C.K., Ward H.C., Ransley P.G., et al. Bladder and kidney function after cure of pelvic rhabdomyosarcoma in childhood. Br J Cancer 70 (1994) 1000-1003
41. Travis L.B., Fossa S.D., Schonfeld S.J., et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97 (2005) 1354-1365
42. Beaty O., Hudson M.M., Greenwald C., et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 1995 13 (1990) 603-609
43. Kriesman H., and Wolkove N. Pulmonary toxicity of antineoplastic therapy. Semin Oncol 19 (1992) 508-520
44. Stover D.E., and Kaner R.J. Pulmonary toxicity. In: De Vita V.T., Hellman S., and Rosenberg S.A. (Eds). Cancer. Principles and practice of oncology. 6th ed. (2001), Williams & Wilkins/Lippincott, Baltimore (MD)/Philadelphia (PA) 2894-2904
45. Skinner R. Chronic ifosfamide nephrotoxicity in children. Med Pediatr Oncol 41 (2003) 190-197
46. Cvitkovic E. Cumulative toxicities from cisplatin therapy and current cytoprotective measures. Cancer Treat Rev 24 (1998) 265-281
47. Bristow M.R., Billingham M.E., Mason J.W., et al. Clinical spectrum of anthracycline cardiotoxicity. Cancer Treat Rep 62 (1978) 873-882
48. Steinherz L.J., and Yahalom J. Cardiac toxicity. In: De Vita V.T., Hellman S., and Rosenberg S.A. (Eds). Cancer. Principles and practice of oncology. 6th ed. (2001), Williams & Wilkins/Lippincott, Baltimore (MD)/Philadelphia (PA) 2904-2921
49. Von Hoff D.D., Layard M.W., Basa P., et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91 (1979) 710-717
50. Lefrak E.A., Pitha J., Rosenheim S., et al. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32 (1973) 302
51. Shan K., Lincoff A.M., and Young J.B. Anthracycline-induced cardiotoxicity. Ann Intern Med 125 (1996) 47-58
52. Grenier M.A., and Lipshultz S.E. Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol 25 (1998) 72-85
53. Kremer L.C., van der Pal H.J., Offringa M., et al. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol 13 (2002) 819-829
54. Atkinson S.A., Halton J.M., Bradley C., et al. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition. Int J Cancer Suppl 11 (1998) 35-39
55. Melby J.C. Clinical pharmacology of systemic corticosteroids. Annu Rev Pharmacol Toxicol 17 (1977) 511-527
56. Smith M.A., Rubinstein L., Anderson J.R., et al. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol 17 (1999) 569-577
57. Jules K.J., and White D.A. Bleomycin-induced pulmonary toxicity. Clin Chest Med 11 (1990) 1
58. Nagarajan R., Neglia J.P., Clohisy D.R., et al. Limb salvage and amputation in survivors of pediatric lower-extremity bone tumours: what are the long-term implications?. J Clin Oncol 20 (2002) 4493-4501
59. Steele G.S., and Richie J.P. Current role of retroperitoneal lymph node dissection in testicular cancer. Oncology 11 (1997) 717-729
60. Heyn R., Newton W.A., Raney R.B., et al. Preservation of the bladder in patients with rhabdomyosarcoma. J Clin Oncol 15 (1997) 69-75
61. Raney B., Heyn R., Hays D.M., et al. Sequelae of treatment in 109 patients followed for 5-15 years after diagnosis of sarcoma of the bladder and prostate. A report from the IRS Committee. Cancer 71 (1993) 2387-2394
62. Speechley K.N., Barrera M., Shaw A.K., Morrison H.I., and Maunsell E. Health-related quality of life among child and adolescent survivors of childhood cancer. J Clin Oncol 24 (2006) 2536-2543
63. Skinner R., Wallace W.H.B., and Levitt G.A. Long-term follow-up of people who have survived cancer during childhood. Lancet Oncol 7 (2006) 489-498
64. Taylor A., Hawkins M., Griffiths A., et al. Long-term follow-up of survivors of childhood cancer in the UK. Pediatr Blood Cancer 42 (2004) 161-168
65. Gharib M.I., and Burnett A.K. Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis. Eur J Heart Failure 4 (2002) 235-242
66. Swain S.M., Whaley F.S., Gerber M.C., et al. Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer. J Clin Oncol 15 (1997) 1318-1332
67. Lipshultz S.E., Lipsitz S.R., Sallan S.E., et al. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol 20 (2002) 4517-4522
68. Villani F., Bacchella L., Bulgheroni A., et al. Study of functional and biochemical indicators of subclinical lung damage in bleomycin-treated patients. Respir Med 86 (1992) 327
69. McBride C.M., Emmons K.M., and Lipkus I.M. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res 18 (2003) 156-170
70. Demark-Wahnefried W., Aziz N.M., Rowland J.H., et al. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 23 (2005) 5813-5830
71. Skinner R, Wallace WHB, Levitt GA, editors. Therapy based long-term follow up: practice statement. UK Children's Cancer Study Group. http://www.ukccsg.org.uk/public/followup/PracticeStatement/index.html (accessed August 24, 2006).
72. Landier W., Bhatia S., Eshelman D.A., et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22 (2004) 4979-4990
73. Long-term follow up of survivors of childhood cancer. A national clinical guideline. Scottish Collegiate Guidelines Network. http://www.sign.ac.uk/pdf/sign76.pdf (accessed August 24, 2006).
74. Ganz P.A. A teachable moment for oncologists: cancer survivors, ten million strong and growing. J Clin Oncol 23 (2005) 5458-5460